We are live on
!
Find out more
CCM
CAAS Capital Management Portfolio holdings
AUM
$934M
1-Year Est. Return
1.45%
This Fund
S&P 500
This Quarter
Est. Return
+26.63%
1 Year Est. Return
+1.45%
3 Year Est. Return
+10.99%
5 Year Est. Return
+150.62%
10 Year Est. Return
–
AUM
$10.5B
AUM Growth
+$6.2B
(+145%)
Cap. Flow
+$4.78B
Cap. Flow
% of AUM
45.54%
Top 10 Holdings %
Top 10 Hldgs %
28.07%
Holding
985
New
521
Increased
87
Reduced
60
Closed
171
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$153M |
| 2 |
Sunrun
RUN
|
+$94.3M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$83.8M |
| 4 |
Dynatrace
DT
|
+$67.2M |
| 5 |
Consolidated Edison
ED
|
+$56.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Solar
FSLR
|
+$71.8M |
| 2 |
10x Genomics
TXG
|
+$62.3M |
| 3 |
Caesars Entertainment
CZR
|
+$60.8M |
| 4 |
Denali Therapeutics
DNLI
|
+$53.1M |
| 5 |
PENN Entertainment
PENN
|
+$42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.01% |
| 2 | Healthcare | 6.25% |
| 3 | Communication Services | 2.7% |
| 4 | Consumer Discretionary | 2.07% |
| 5 | Financials | 1.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVGOW
801
DELISTED
EVgo Inc Warrants
EVGOW
| $45K | ﹤0.01% |
+25,000
| New | +$40.1K |
|
|
RVLP
802
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $45K | ﹤0.01% |
10,977
-455,338
| -98% | -$2.62M |
|
803
CALL
Vodafone
VOD
$36.3B
| $16K | ﹤0.01% |
+1,000
| New | +$15.6K |
|
804
Regeneron Pharmaceuticals
REGN
$78.5B
| $10K | ﹤0.01% |
+20
| New | +$10.8K |
|
805
Johnson & Johnson
JNJ
$618B
| $8K | ﹤0.01% |
50
-6,450
| -99% | -$952K |
|
806
CALL
AbbVie
ABBV
$443B
| – | – |
-170,000
| Closed | -$14.9M |
|
807
Abbott
ABT
$183B
| – | – |
-14,250
| Closed | -$1.55M |
|
808
Accel Entertainment
ACEL
$978M
| – | – |
-100,000
| Closed | -$1.07M |
|
809
Albertsons Companies
ACI
$5.62B
| – | – |
-1,250,000
| Closed | -$17.3M |
|
810
ADC Therapeutics
ADCT
$134M
| – | – |
-35,000
| Closed | -$1.16M |
|
811
ADT
ADT
$5.58B
| – | – |
-1,859,520
| Closed | -$15.2M |
|
|
ADVM
812
DELISTED
Adverum Biotechnologies
ADVM
| – | – |
-25,008
| Closed | -$2.58M |
|
813
Agnico Eagle Mines
AEM
$73.6B
| – | – |
-11,200
| Closed | -$836K |
|
814
CALL
AGNC Investment
AGNC
$12.4B
| – | – |
-31,600
| Closed | -$440K |
|
815
American International
AIG
$41.7B
| – | – |
-14,000
| Closed | -$493K |
|
816
Antero Midstream
AM
$10.4B
| – | – |
-1,253,753
| Closed | -$6.73M |
|
817
Applied Materials
AMAT
$403B
| – | – |
-6,500
| Closed | -$480K |
|
818
Amgen
AMGN
$208B
| – | – |
-4,000
| Closed | -$1.02M |
|
|
819
PUT
Amgen
AMGN
$208B
| – | – |
-12,200
| Closed | -$3.1M |
|
820
Annexon
ANNX
$835M
| – | – |
-25,000
| Closed | -$756K |
|
821
AppFolio
APPF
$6.38B
| – | – |
-155,592
| Closed | -$22.1M |
|
|
AZEK
822
DELISTED
The AZEK Co
AZEK
| – | – |
-202,868
| Closed | -$7.06M |
|
823
Alibaba
BABA
$293B
| – | – |
-146,500
| Closed | -$40.7M |
|
824
KE Holdings
BEKE
$18.7B
| – | – |
-250,000
| Closed | -$15.3M |
|
825
BILL Holdings
BILL
$4.49B
| – | – |
-132,668
| Closed | -$15.6M |
|
Similar funds
CIG
TAM
WCF
CHP
SWC
KTA
LC
SBIA
CAAS Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, CAAS Capital Management held 985 positions worth $10.5B, up 145% from $4.29B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
CAAS Capital Management deployed $4.78B of net new capital in Q4 2020, opening 521 new positions and adding to 87 existing holdings. Its largest new stake was Sunrun: 1,519,346 shares worth $105M.
By sector, the portfolio is most concentrated in Technology at 7% of assets, down from 7.8% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was First Solar, an estimated $71.8M trimmed.
- CAAS Capital Management's largest Q4 2020 buy was Sunrun: 1,519,346 shares worth $105M.
- CAAS Capital Management added most to Royalty Pharma in Q4 2020, an estimated $153M increase.
- CAAS Capital Management's biggest Q4 2020 reduction was First Solar, cutting an estimated $71.8M.
- CAAS Capital Management fully exited 10x Genomics in Q4 2020, selling an estimated $62.3M.
- CAAS Capital Management's ten largest holdings make up 28% of its $10.5B portfolio in Q4 2020.
- CAAS Capital Management opened 521 new positions and closed 171 in Q4 2020.
- CAAS Capital Management's portfolio value rose 145% quarter-over-quarter to $10.5B.
Based on CAAS Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.